These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2890221)
1. HLA class I- like antigen expression on human leukemic cells. Peruccio D; Crepaldi T; Lovisone E; Paolino F; Foa R; Castagnoli C; Gabrielli A; Cappa PM; Richiardi P Tissue Antigens; 1987 Aug; 30(2):76-83. PubMed ID: 2890221 [TBL] [Abstract][Full Text] [Related]
2. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells. Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361 [TBL] [Abstract][Full Text] [Related]
3. New HLA class I-like alloantigens expressed on blast cells. Crepaldi T; Peruccio D; Lecchi M; Resegotti L; Grazia Guerra M; Funaro A; Richiardi P J Immunogenet; 1987; 14(4-5):219-29. PubMed ID: 3331642 [TBL] [Abstract][Full Text] [Related]
4. Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation. Chan KW; Pollack MS; Braun D; O'Reilly RJ; Dupont B Transplantation; 1982 Jun; 33(6):613-5. PubMed ID: 6954756 [TBL] [Abstract][Full Text] [Related]
5. New human MHC class I antigens segregating with HLA-A antigens detected on some lymphocyte subpopulations. Mitsuishi Y; Falkenrodt A; Urlacher A; Tongio MM; Mayer S Hum Immunol; 1986 Feb; 15(2):175-97. PubMed ID: 3485086 [TBL] [Abstract][Full Text] [Related]
6. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells. van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823 [TBL] [Abstract][Full Text] [Related]
7. HLA class I and class II antigen associations in acute leukaemias. Navarrete C; Alonso A; Awad J; McCloskey D; Ganesan TS; Amess J; Lister TA; Festenstein H J Immunogenet; 1986; 13(2-3):77-84. PubMed ID: 3469278 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage. Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962 [TBL] [Abstract][Full Text] [Related]
9. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. Lee SK; Oliver RT J Exp Med; 1978 Mar; 147(3):912-22. PubMed ID: 305461 [TBL] [Abstract][Full Text] [Related]
10. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro. Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050 [TBL] [Abstract][Full Text] [Related]
11. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. Sondel PM; O'Brien C; Porter L; Schlossman SF; Chess L J Immunol; 1976 Dec; 117(6):2197-203. PubMed ID: 1069027 [TBL] [Abstract][Full Text] [Related]
12. HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia. von Fliedner VE; Sultan Khan Z; Jeannet M Acta Haematol; 1981; 65(2):73-8. PubMed ID: 6785965 [TBL] [Abstract][Full Text] [Related]
13. HLA class I antigens on normal and leukemic cells (quantitative analysis). Urlacher A; Falkenrodt A; Tongio MM; Mayer S Tissue Antigens; 1987 May; 29(5):237-45. PubMed ID: 2821653 [TBL] [Abstract][Full Text] [Related]
14. [Expression of class I and class II markers on populations of leukemic cells]. Tongio MM; Falkenrodt A; Urlacher A; Mitsuishi Y; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard X; Mayer S Pathol Biol (Paris); 1986 Jun; 34(6):753-7. PubMed ID: 3531991 [TBL] [Abstract][Full Text] [Related]
15. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Janossy G; Coustan-Smith E; Campana D Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463 [TBL] [Abstract][Full Text] [Related]
16. Deficient expression of class-I HLA in some cases of acute leukemia. Elkins WL; Pickard A; Pierson GR Cancer Immunol Immunother; 1984; 18(2):91-100. PubMed ID: 6239685 [TBL] [Abstract][Full Text] [Related]
17. IEF analysis of HLA molecules immunoprecipitated by putative anti-class I-like alloantisera. Crepaldi T; D'Alfonso S; Richiardi P J Immunogenet; 1990 Dec; 17(6):409-13. PubMed ID: 1710635 [TBL] [Abstract][Full Text] [Related]
18. Study of the levels of expression of two oncogenes, c-myc and c-myb, in acute and chronic leukemias of both lymphoid and myeloid lineage. Ferrari S; Torelli U; Selleri L; Donelli A; Venturelli D; Narni F; Moretti L; Torelli G Leuk Res; 1985; 9(7):833-42. PubMed ID: 3860696 [TBL] [Abstract][Full Text] [Related]
19. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation. Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337 [TBL] [Abstract][Full Text] [Related]
20. TCA: a polymorphic genetic marker in leukemias and melanoma cell lines. van Leeuwen A; Schrier PI; Giphart MJ; Noordermeer IA; Ruiter DJ; Rubinstein P; van Rood JJ Blood; 1986 Apr; 67(4):1139-42. PubMed ID: 3485457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]